| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f0e9d6fd987d30c27f058703c7ad14b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-90 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
1996-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e287ca0614749a9d4970fa1b3d0049a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea171c135b7dcb24e85adcd00fefb2c1 |
| publicationDate |
2000-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6083756-A |
| titleOfInvention |
Prevention of sudden infant death |
| abstract |
PCT No. PCT/SE96/01428 Sec. 371 Date May 7, 1998 Sec. 102(e) Date May 7, 1998 PCT Filed Nov. 6, 1996 PCT Pub. No. WO97/17612 PCT Pub. Date May 15, 1997A method for identification of an infant being particularly susceptible to sudden infant death syndrome (SIDS) comprises the determination of an Helicobacter pylori infection in the infant's mother, particularly by detection of antibodies to H. pylori of the IgG type, in a blood sample drawn from the infant's mother or by determination of carbon dioxide formed from urea in the air exhaled from the infant's mother upon oral administration of a challenge dose of urea. Also disclosed is the use of an antibiotic effective against H. pylori for the manufacture of a medicament for administration to mothers and other persons infected by H. pylori and coming into close bodily contact with infants below two years of age, and a method of prevention of SIDS by administration of that antibiotic. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7733233-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9572528-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007087395-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103376317-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103376317-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003148411-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008094226-A1 |
| priorityDate |
1995-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |